At a glance
ClinicalIndex Comparison RecordN/ACompleted
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
KSHV Seroprevalence in Hospital Patients From San Antonio
The University of Texas Health Science Center at San Antonio·observational·Posted Sep 29, 2000·Updated Mar 10, 2016
In Brief
An observational study for Blood Donors and 5 related conditions. Completed.
Detailed Summary
To determine the seroprevalence of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8) in blood donors from Texas. Also to examine the donors' demographic characteristics and to characterize the KSHV using polymerase chain reaction.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBlood Donors, Acquired Immunodeficiency Syndrome, Blood Transfusion, Herpesvirus, Kaposi Sarcoma-Associated, Sarcoma, Kaposi, HIV Infections
Countries--
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI)
Timeline
N/ACompletedFinished
19992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 1999
First PostedSep 2000
Study CompletionMar 2004
TodayJul 2026
First PostedSep 29, 2000
Enrollment StartApr 1, 1999
Study CompletionMar 1, 2004
TodayJul 2, 2026
Posted 25.8 years ago